Table 2.
Current JAK inhibitor clinical trials for patients with an MPN
IMID indicates immunomodulatory drugs; N/A, not applicable.
Current JAK inhibitor clinical trials for patients with an MPN
IMID indicates immunomodulatory drugs; N/A, not applicable.
